Wall Street eyes stock in athleisure brands and energy-drink makers as big winners in the Ozempic craze

UCG/Getty

• The rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro is going to have a big impact on consumer spending habits.
• Stifel conducted a survey of consumers and highlighted the potential winners as more people lose weight from the drugs.
• Athleisure brands like Lululemon could see a jump in demand, as could energy drink makers.

The continued rise of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro is going to have a big impact on consumer spending habits as more people lose weight...